Sarepta Therapeutics
SRPT
SRPT
365 hedge funds and large institutions have $4.96B invested in Sarepta Therapeutics in 2021 Q1 according to their latest regulatory filings, with 62 funds opening new positions, 140 increasing their positions, 117 reducing their positions, and 145 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less ownership
Funds ownership: →
less funds holding
Funds holding: →
less call options, than puts
Call options by funds: $ | Put options by funds: $
57% less first-time investments, than exits
New positions opened: 62 | Existing positions closed: 145
59% less capital invested
Capital invested by funds: $12.1B → $4.96B (-$7.1B)
100% less funds holding in top 10
Funds holding in top 10: 5 → 0 (-5)
Holders
365
Holding in Top 10
–
Calls
$116M
Puts
$149M
Top Buyers
| 1 | +$212M | |
| 2 | +$189M | |
| 3 | +$149M | |
| 4 |
Voloridge Investment Management
Jupiter,
Florida
|
+$49.1M |
| 5 |
Bank of New York Mellon
New York
|
+$46.8M |
Top Sellers
| 1 | -$218M | |
| 2 | -$148M | |
| 3 | -$124M | |
| 4 |
Artisan Partners
Milwaukee,
Wisconsin
|
-$90.5M |
| 5 |
WRF
Waddell & Reed Financial
Overland Park,
Kansas
|
-$86.9M |